
Top US trade negotiator meets Pfizer, AstraZeneca execs on Covid-19 IP waiver
India Today
Democratic lawmakers, civil society groups, and 60 former heads of state and 100 Nobel Prize winners have urged President Joe Biden to back the waiver.
US Trade Representative Katherine Tai on Monday met virtually with top executives of drugmakers Pfizer and AstraZeneca PLC to discuss a proposed waiver of certain intellectual property rights in response to the Covid-19 pandemic. Members of the World Trade Organization are due to discuss a proposal by India and South Africa to waive certain provisions of the WTO's Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) on April 30, but the United States and a few other big countries have blocked such a move. Democratic lawmakers, civil society groups, and 60 former heads of state and 100 Nobel Prize winners have urged President Joe Biden to back the waiver. White House Press Secretary Jen Psaki on Monday said she had no updates on the issue.
Oil and gas refineries and hubs are up in flames not just in the Middle East, but also in Russia and the US. Crude oil prices have surged over $100 a barrel. With the energy infrastructure in the Middle East likely to take years to be rebuilt, the world could be set for the biggest oil disruption in history.

Speaking at the White House, Trump said the United States was in contact with "the right people" in Iran and suggested that Tehran was eager to reach an agreement to halt hostilities. "We're in negotiations right now," he told reporters, without offering further details on the scope or format of the talks.











